Up to $2 M is available to support the development and commercialisation of early-stage medical research discoveries.
The Medical Research Commercialisation Fund (MRCF) is an innovative investment collaboration which invests in life science opportunities from its member medical research institutes and their associated hospitals throughout Australia.
The Medical Research Commercialisation Fund (MRCF) provides its Members with a range of benefits, including:
- An early-stage fund dedicated to supporting the development and commercialisation of early-stage medical technologies;
- Access to risk-tolerant investment capital to support the development of promising technologies,
- Involvement in and exposure to the Investment Review process; and
- The investors gain access to promising technologies emanating from the Member Institutes.
Established in 2007, investment funding from the Medical Research Commercialisation Fund (MRCF) is available to promising opportunities from its 50 member institutes.
The MRCF’s investors are AustralianSuper, Statewide Super, HESTA, HOSTPLUS and the Australian Government under its IIF program. The MRCF acknowledges support from the State Governments of Victoria, New South Wales, Western Australia, Queensland and South Australia.
MRCF is managed by Brandon Capital Partners, a life science fund manager, and each member institute nominates a representative to the Investment Review Committee (IRC). The MRCF has received $30 million in funding from superannuation funds and $20 million from the Federal Government’s IIF program.
MRCF provides funding of $200,000 to $2 million for any one project, investing up to $1 million on its own, and reserves the second $1 million for further rounds of investment made alongside co-investors. It also provides financial and strategic management assistance.
Eligible applicants include medical research institutes. The MRCF invests exclusively in opportunities from its member institutes.
Eligible activities include opportunities with milestone-based development programs requiring smaller first round financial commitments to generate further exemplification of the technology.
Application is open on an ongoing basis.